128 related articles for article (PubMed ID: 11824579)
41. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
[TBL] [Abstract][Full Text] [Related]
42. New steroidal lactones as 5α-reductase inhibitors and antagonists for the androgen receptor.
Garrido M; Bratoeff E; Bonilla D; Soriano J; Heuze Y; Cabeza M
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):367-73. PubMed ID: 21782943
[TBL] [Abstract][Full Text] [Related]
43. 5 alpha-reductase inhibition by a new synthetic steroid (PM-9) in cultures of Penicillium crustosum.
Cabeza M; Quiroz A; Bratoeff E; García G; Ramírez E; Flores E
Proc West Pharmacol Soc; 2002; 45():164-5. PubMed ID: 12434569
[TBL] [Abstract][Full Text] [Related]
44. Antiandrogen. II. Oxygenated 2-oxapregnane steroids.
Takegawa S; Koizumi N; Takahashi H; Shibata K
Chem Pharm Bull (Tokyo); 1993 May; 41(5):870-5. PubMed ID: 7687931
[TBL] [Abstract][Full Text] [Related]
45. Assignment of anabolic-androgenic and antiandrogenic properties to some chlorine-substituted steroids on the basis of their binding characteristics to the androgen receptor of the rat seminal vesicle.
Zakár T; Kaufmann G; Tóth M
Exp Clin Endocrinol; 1986 Jul; 87(2):133-41. PubMed ID: 3758193
[TBL] [Abstract][Full Text] [Related]
46. New progesterone derivatives as inhibitors of 5alpha-reductase enzyme and prostate cancer cell growth.
Cabeza M; Bratoeff E; Heuze I; Rojas A; Terán N; Ochoa M; Ramírez-Apan T; Ramírez E; Pérez V; Gracia I
J Enzyme Inhib Med Chem; 2006 Aug; 21(4):371-8. PubMed ID: 17059168
[TBL] [Abstract][Full Text] [Related]
47. Antiandrogenic steroidal sulfonylpyrazoles.
Christiansen RG; Bell MR; D'Ambra TE; Mallamo JP; Herrmann JL; Ackerman JH; Opalka CJ; Kullnig RK; Winneker RC; Snyder BW
J Med Chem; 1990 Aug; 33(8):2094-100. PubMed ID: 2374140
[TBL] [Abstract][Full Text] [Related]
48. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
[TBL] [Abstract][Full Text] [Related]
49. Effect of the antiandrogen, WIN 49,596, on the descent of the testis in the male rat.
Bluestein D; Lemmi CA; Miller L; Geesaman B; Rajfer J
J Urol; 1991 May; 145(5):1103-5. PubMed ID: 2016802
[TBL] [Abstract][Full Text] [Related]
50. Fungi test for evaluation of new antiandrogenic molecule.
Cabeza M; Quiroz A; Bratoeff E; Heuze I; Ramírez E; Murillo E
Proc West Pharmacol Soc; 2000; 43():29-30. PubMed ID: 11056949
[TBL] [Abstract][Full Text] [Related]
51. Androgen receptor binding and antiandrogenic activity of some 4,5-secoandrostanes and ring B cyclopropanoandrostanes.
Stárka L; Hampl R; Kasal A; Kohout L
J Steroid Biochem; 1982 Sep; 17(3):331-4. PubMed ID: 6215537
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of pregnane derivatives, their cytotoxicity on LNCap and PC-3 cells, and screening on 5alpha-reductase inhibitory activity.
Kim S; Ma E
Molecules; 2009 Nov; 14(11):4655-68. PubMed ID: 19924093
[TBL] [Abstract][Full Text] [Related]
53. Novel dehydroepiandrosterone benzimidazolyl derivatives as 5α-reductase isozymes inhibitors.
Arellano Y; Bratoeff E; Segura T; Mendoza ME; Sánchez-Márquez A; Medina Y; Heuze Y; Soriano J; Cabeza M
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):908-14. PubMed ID: 26394987
[TBL] [Abstract][Full Text] [Related]
54. Antiandrogen. I. 2-azapregnane and 2-oxapregnane steroids.
Shibata K; Takegawa S; Koizumi N; Yamakoshi N; Shimazawa E
Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):935-41. PubMed ID: 1381997
[TBL] [Abstract][Full Text] [Related]
55. Suppressive effects of the antiandrogen agent, chlormadinone acetate and the 5alpha-reductase inhibitor, dutasteride on prostate weight and intraprostatic androgen levels in rats.
Kobayashi H; Gotanda K; Shibata Y; Watanabe J; Nakano Y; Shinbo A; Suzuki K
Arzneimittelforschung; 2011; 61(9):515-20. PubMed ID: 22029228
[TBL] [Abstract][Full Text] [Related]
56. Effect of dehydroepiandrosterone derivatives on the activity of 5α-reductase isoenzymes and on cancer cell line PC-3.
Bratoeff E; Garrido M; Ramírez-Apan T; Heuze Y; Sánchez A; Soriano J; Cabeza M
Bioorg Med Chem; 2014 Nov; 22(21):6233-41. PubMed ID: 25261928
[TBL] [Abstract][Full Text] [Related]
57. The local antiandrogenic effect of the intracutaneous injection of progesterone in the flank organ of sexually mature male Syrian golden hamster.
Orentreich N; Matias JR; Malloy V
Arch Dermatol Res; 1984; 276(6):401-5. PubMed ID: 6517612
[TBL] [Abstract][Full Text] [Related]
58. Effect of androgen concentration on seminal vesicle blood flow in rats-establishment of new highly sensitive simultaneous androgen measurement method.
Kashiwagi B; Shibata Y; Ono Y; Suzuki K; Honma S; Yamanaka H
Urology; 2005 Jul; 66(1):218-23. PubMed ID: 15992887
[TBL] [Abstract][Full Text] [Related]
59. Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa Roxb.
Suphrom N; Pumthong G; Khorana N; Waranuch N; Limpeanchob N; Ingkaninan K
Fitoterapia; 2012 Jul; 83(5):864-71. PubMed ID: 22465508
[TBL] [Abstract][Full Text] [Related]
60. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
